Dianthus Therapeutics Inc. (DNTH) — Cash Flow-to-Debt Ratio
Dianthus Therapeutics Inc. (DNTH) has a Cash Flow-to-Debt Ratio of -1.25x as of December 2025, meaning its operating cash flow of $-46.98 Million could theoretically repay -1% of its total liabilities ($37.52 Million) in one year. See DNTH free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dianthus Therapeutics Inc. Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Dianthus Therapeutics Inc. across 10 annual periods. Also explore Dianthus Therapeutics Inc. (DNTH) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Dianthus Therapeutics Inc. (2016–2025)
Year-by-year debt coverage analysis for Dianthus Therapeutics Inc.. For market capitalisation and broader financial context, see Dianthus Therapeutics Inc. (DNTH) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.44x | $-129.06 Million | $37.52 Million | ▲ +5.3% |
| 2024 | -3.63x | $-78.18 Million | $21.53 Million | ▼ -3.8% |
| 2023 | -3.50x | $-36.86 Million | $10.54 Million | ▼ -13.8% |
| 2022 | -3.07x | $-29.07 Million | $9.45 Million | ▲ +10.8% |
| 2021 | -3.45x | $-59.53 Million | $17.26 Million | ▲ +4.6% |
| 2020 | -3.61x | $-64.02 Million | $17.71 Million | ▼ -28.6% |
| 2019 | -2.81x | $-57.10 Million | $20.32 Million | ▲ +21.7% |
| 2018 | -3.59x | $-41.89 Million | $11.66 Million | ▲ +33.2% |
| 2017 | -5.37x | $-22.26 Million | $4.14 Million | ▼ -89.3% |
| 2016 | -2.84x | $-6.53 Million | $2.30 Million | — |